AVA
Atlas Venture Advisors Portfolio holdings
AUM
$424M
This Quarter Return
+63.19%
1 Year Return
+0.16%
3 Year Return
+108.89%
5 Year Return
+64.67%
10 Year Return
–
AUM
$464M
AUM Growth
+$464M
(+60%)
Cap. Flow
-$3.63M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
|
$3.63M |
Sector Composition
| 1 | Communication Services | 71.24% |
| 2 | Consumer Discretionary | 27.33% |
| 3 | Healthcare | 1.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Integral Ad Science
IAS
$1.49B
| $324M | 69.83% | 22,722,771 | – | – |
|
2
DraftKings
DKNG
$23.8B
| $127M | 27.33% | 6,555,608 | – | – |
|
3
Viridian Therapeutics
VRDN
$1.5B
| $5.33M | 1.15% | 209,505 | – | – |
|
4
Roku
ROKU
$14.2B
| $3.8M | 0.82% | 57,707 | – | – |
|
5
Snap
SNAP
$12.1B
| $2.75M | 0.59% | 245,559 | – | – |
|
6
Larimar Therapeutics
LRMR
$310M
| $1.32M | 0.29% | 292,184 | – | – |
|
|
FSTX
7
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| – | – | -574,996 | Closed | -$3.63M |
|